In patients with ccRCC from TCGA database, we observed that DRD2 expression was positively correlated with GLI1, OCT4, and Nanog expressions (Fig. 7F) and poor prognoses of patients (Fig. 7G). This evidence concerns the gene POU5F1 and nonpapillary renal cell carcinoma.